Linden Thomas Advisory Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Sell
35,235
-646
-2% -$33.6K 0.2% 161
2025
Q1
$2.29M Buy
35,881
+890
+3% +$56.8K 0.3% 102
2024
Q4
$1.67M Sell
34,991
-349
-1% -$16.7K 0.21% 171
2024
Q3
$2.02M Buy
35,340
+12
+0% +$687 0.28% 119
2024
Q2
$1.85M Sell
35,328
-7,169
-17% -$375K 0.29% 108
2024
Q1
$1.73M Buy
42,497
+40
+0.1% +$1.63K 0.28% 124
2023
Q4
$1.57M Buy
42,457
+7
+0% +$259 0.29% 127
2023
Q3
$1.62M Buy
42,450
+5,126
+14% +$196K 0.36% 79
2023
Q2
$1.35M Buy
37,324
+181
+0.5% +$6.53K 0.3% 129
2023
Q1
$1.42M Buy
37,143
+894
+2% +$34.1K 0.35% 108
2022
Q4
$2.06M Buy
+36,249
New +$2.06M 0.58% 29